HCC
Upon pharmacological treatment with demethylating agent 5-aza-2'-deoxycytidine or histone deacetylase inhibitor trichostatin A, T-cadherin promoter hypermethylation and/or histone deacetylation was frequently observed in HCC samples and cell lines.
Upon pharmacological treatment with demethylating agent 5-aza-2'-deoxycytidine or histone deacetylase inhibitor trichostatin A, <span class="gene" id="18553387-7-128-138">T-cadherin</span> promoter hypermethylation and/or histone deacetylation was frequently observed in <span class="disease" id="18553387-7-221-224">HCC</span> samples and cell lines.